Sponsors (2)
The bill splits NIAID into three disease-focused institutes to improve targeted research and leadership clarity, but risks transition costs, slower coordination, and potential politicization of research priorities.
Researchers and public-health officials will gain specialized institutes focused on infectious, allergic, and immunologic diseases, improving targeted research and outbreak response capabilities.
Federal employees and institute stakeholders will have clearer leadership accountability through new presidentially appointed directors with fixed five-year terms.
State governments and health-system partners will face clearer statutory authorities and program jurisdiction due to the statutory reorganization, reducing legal ambiguity over which institute oversees specific programs.
Scientists, patients, and the public could see research priorities influenced by political considerations because institute directors are presidentially appointed.
Researchers and taxpayers may bear short-term administrative disruption and transition costs from splitting NIAID, which could divert funding away from ongoing research programs.
Patients with chronic conditions and health systems could experience slower coordination and decision-making across related research areas during the transition to three separate institutes.
Based on analysis of 2 sections of legislative text.
Splits NIAID into three institutes (allergic, infectious, immunologic), redesignates statutes, and creates presidential appointment rules for three Directors.
Splits the current National Institute of Allergy and Infectious Diseases (NIAID) into three separate institutes—one each for allergic diseases, infectious diseases, and immunologic diseases—by amending the Public Health Service Act and redesignating existing statutory provisions. It terminates the existing NIAID Director position, creates presidential appointment authority for the three new institute directors with five-year terms (one reappointment allowed), and provides transition rules to carry existing authorities and references to the appropriate new institute.
Official title: Replace the National Institute of Allergy and Infectious Diseases with 3 separate national research institutes.
Introduced February 20, 2025 by Rand Paul · Last progress February 20, 2025